Matching Weight Health Strategy to Employer Goals

The challenge for benefits leaders today isn’t deciding whether GLP‑1s are good or bad. It's figuring out what makes sense for each organization, given its budget, culture, and goals, while balancing access, outcomes, and affordability in a sustainable way.

Transcarent knows that no two employers start from the same place. A recent survey found that 67% of employers currently cover GLP-1s for weight management.¹ Others don’t cover GLP‑1s for weight at all, while some have opened access widely and may be struggling to manage spend. Many are somewhere in between, updating policies as new therapies, headlines, and Member expectations emerge.

The question isn’t “Should we cover GLP‑1s?” but “How do we balance access, outcomes, and affordability in a way that fits our reality?” Transcarent created Weight Health Direct, a GLP‑1 carve-out model for our Weight Health Care Experience, to answer this question and meet this need. It gives employers the choice and customization they need to further personalize Weight Health for their employee populations.

Why GLP‑1 coverage needs customization

GLP‑1s are unlike almost any other drug category. Demand is growing quickly, new indications and dosage forms are expanding the eligible population, and the pace of change is outstripping traditional benefit models. The rebate‑driven pharmacy benefit management (PBM) structure—built around high list prices, negotiated discounts, and complex formulary tiers—wasn’t designed for this type of runaway utilization and intense Member demand.

At the same time, the market is flooded with “solutions” as employers consider PBM add-on programs, direct-to-consumer and cash-pay options, point solutions, and emerging direct-to-employer models. It can feel like a choice between Member dissatisfaction and spiraling, unpredictable costs.

And the stakes are different for every employer. A self-funded tech company competing for talent and facing a high demand for GLP-1s will make different trade-offs than a public-sector employer with strict budget oversight and public accountability. Weight Health Direct takes a sustainable approach by allowing employers to customize coverage based on their priorities, rather than assume every employer could tolerate the same level of risk, disruption, or cost-sharing.

Think “whole‑person Weight Health,” not just a drug program

Employers also must consider clinical appropriateness. One of the biggest risks is treating GLP‑1s as a standalone quick fix. Many weight management and diabetes programs today are aimed at a single condition, disconnected from broader benefits, and not designed to bend the cost curve. Transcarent’s Weight Health solution starts by asking: Can the approach solve the full problem?

Instead of isolating one medication class or diagnosis, Weight Health is built as a configurable foundation for weight and cardiometabolic health. Members get a clinician‑led experience that can include lifestyle support, medication management (including GLP‑1s where appropriate and aligned with policy), and bariatric surgery when it’s the right clinical choice. Care is matched to each Member’s needs and to each employer’s policies and philosophy.

Weight Health Direct: control and clarity for GLP‑1 coverage

Within that whole‑person approach, GLP‑1s for weight still need special attention. That’s where Weight Health Direct comes in. It can be deployed on a spectrum, allowing employers to choose what best fits their financial goals, workforce, and culture. With Weight Health Direct, GLP-1s for weight management are carved out from the traditional PBM and administered under a distinct benefit with a fixed, transparent price and a limited home-delivery pharmacy network.

It works alongside existing pharmacy benefits, rather than replacing an entire pharmacy strategy, while zeroing in on the part that’s not working today: GLP-1 access and cost. Now, instead of asking, “Should we cover GLP‑1s or not?” employers can ask a more strategic question: “How do we design GLP‑1 coverage and metabolic care that’s financially sustainable and culturally aligned for our organization?” For some employers, that will mean a conservative initial configuration with tight guardrails; for others, it may mean leaning into access with careful tracking and a clear story for leadership. With Weight Health Direct, employers gain:

• Control of costs and coverage. Define which Members are eligible, how costs are shared, and how GLP‑1s are positioned within the broader Weight Health strategy.

• Full transparency. Get clear visibility into actual drug and delivery costs, without relying on opaque rebate mechanics or “black box” guarantees.

• Predictable spend. Instead of “wait and see” rebate economics, employers move to a known, fixed price per fill that makes GLP‑1 spend easier to forecast, explain, and manage.

• Flexible integration. Use Weight Health Direct as a GLP‑1 carve‑out alongside current benefits, or pair it with the full Weight Health program for an integrated experience.

• No Member disruption. Members can keep existing clinical relationships, avoiding wholesale formulary upheaval or abrupt changes to care pathways.

Where to go from here

GLP‑1s will continue to reshape pharmacy spend, clinical practice, and Member expectations, but no two employers should be expected to navigate that shift in the same way. A better path combines whole‑person Weight Health care with a transparent, configurable GLP‑1 model that respects each employer’s requirements, risk tolerance, and culture.

Transcarent can help employers move beyond either/or debates and toward a “fit‑for‑purpose” GLP-1 strategy. Watch our on‑demand webinar for a deeper dive into how Weight Health and Weight Health Direct work together, or just ask us - and we'll explore what the right approach looks like together.

1. Business Group on Health. Coverage for GLP-1s: Employer Perspectives and Strategies. 2026.